AzTrials
AzTrials

FastingNCT05737641

Gastric Volume After Water or Jelly Ingestion

A study testing water ingestion and jelly ingestion in people with Fasting and Surgery, run by Centro Hospitalar de Entre o Douro e Vouga at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine whether the fasting duration required for patients after consuming oral jelly is comparable to that after consuming water, prior to elective surgery. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
water ingestion and jelly ingestion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 sitePortugal
Study dates
1 Dec 2022to 25 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult volunteers working in the hospital Centro Hospitalar de Entre o Douro e Vouga (CHEDV)

Who cannot join

  • morbid obesity
  • pregnancy
  • alcohol abuse
  • diseases or drugs that can prolong or accelerate gastric emptying such as gastric or esophageal surgery, diabetes mellitus, prokinetic or opioid use, hypothyroidism
  • intolerance to any of the components of jelly

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Centro Hospitalar de Entre Douro e Vouga (CHEDV)

    Santa Maria da Feira, Aveiro District, 4520-211

Other trials in Portugal

About this study

Official title: Ultrasonographic Evaluation of Gastric Content and Volume After Oral Ingestion of Water or Jelly in Volunteers - A Randomised Controlled Non-inferiority Clinical Trial

The aim of this study is to determine whether the fasting duration required for patients after consuming oral jelly is comparable to that after consuming water, prior to elective surgery.

International guidelines for perioperative fasting recommend abstaining from clear fluids for 2 hours to minimize the risk of regurgitation and aspiration pneumonia. However, there are no specific recommendations regarding the perioperative management of jelly consumption.

Read more

Current understanding emphasizes the benefits of minimizing preoperative fasting time, including preventing dehydration and metabolic complications like ketoacidosis, as well as potentially enhancing patient satisfaction.

Oral jelly consumption may offer advantages by improving preoperative hydration and providing some nutritional support prior to procedures.

This crossover study will involve 25 adult volunteers. In the first phase, participants will be randomly assigned to either oral intake of water or jelly, followed by the opposite intervention in the second phase. Gastric content and volume will be assessed using gastric ultrasound.

Read the detailed description

Prolonged preoperative fasting is associated with unfavorable outcomes, inducing a catabolic state that may lead to metabolic disturbances such as ketoacidosis, insulin resistance, dehydration, and increased postoperative complications such as surgical site infection and delayed bowel function. To minimize fasting time, current guidelines from the American Society of Anesthesiology advise clear fluid intake (water, tea, coffee, pulp-free fruit juices, carbohydrate-rich beverages) up to 2 hours prior to elective procedures involving general anesthesia, regional anesthesia, or procedural sedation and analgesia. Solids fasting should extend to 6 to 8 hours, depending on the type of foods.

Jelly is a solid food, mostly composed of water. Among its other components, proteins, responsible for its solidification, and sugars stand out. Thus, it may be a form of oral hydration, associated with some nutritional value, but the appropriate preoperative fasting time is not explicitly stated in the guidelines.

An important cause of mortality and morbidity associated with tracheal intubation is the aspiration of gastric contents. It is important to ensure that restricting preoperative fasting time does not compromise patient safety, thereby increasing this risk. While carbohydrate-rich beverages are not associated with delays in gastric emptying, the same cannot be said for protein-containing liquids.

Gastric ultrasound is a non-invasive, bedside-available, and reliable method for quantitative and qualitative assessment of stomach contents. Although the minimum volume of gastric contents associated with increased risk of aspiration is not known, some studies demonstrate that volumes up to 1.5 mL/kg of clear fluids, in the absence of solid contents, are normal, commonly seen in fasting adults, and are not associated with an increased risk of pulmonary aspiration.

The aim of our study is to demonstrate that jelly ingestion, compared to water, is not associated with larger cross-sectional area of the gastric antrum, behaving similarly to clear fluids.

Being tested
water ingestion, jelly ingestion
Keywords
Preoperative Fasting, Elective Surgery, Ultrasound, Gastric Volume, Jelly, Regurgitation, Aspiration pneumonia
Medical subject headings
Fasting, Gastroesophageal Reflux, Pneumonia, Aspiration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • water ingestionOther

    ingestion of water after an 8h-fasting period

  • jelly ingestionDietary supplement

    ingestion of jelly after an 8h-fasting period

Study groups in NCT05737641
Study groupRoleWhat they receive
water ingestionActive comparatorIngestion of 102 mL of fresh water
Receives: Other: water ingestion
jelly ingestionExperimentalingestion of 100 gr strawberry jelly
Receives: Dietary Supplement: jelly ingestion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. gastric antral cross-sectional area

    antral cross-sectional area measured by ultrasound in right lateral decubitus position (non-inferiority test)

    Measured: 2 hours after intervention

Secondary outcomes (4)
  1. gastric volume

    gastric volume calculated by the formula of Perlas et al

    Measured: 2 hours after intervention

  2. gastric volume greater than 1.5 mL/Kg

    number of participants with gastric volume greater than 1.5 mL/kg

    Measured: 2 hours after intervention

  3. Qualitative gastric evaluation

    Empty, fluid or solid

    Measured: 2 hours after intervention

  4. hunger and thirst

    hunger and thirst on a visual analogue scale from 0 to 10

    Measured: 2 hours after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start1 Dec 2022
  3. Primary completion1 Jul 2023
  4. Study completion25 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Model description
RCT crossover study
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05737641
Sponsor's protocol ID
CES 48_2022
Status last verified
Aug 2024
First submitted
23 Dec 2022
Last updated
27 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing water ingestion and jelly ingestion in people with Fasting and Surgery, run by Centro Hospitalar de Entre o Douro e Vouga at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

gastric antral cross-sectional area (time frame: 2 hours after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in